Results

Janssen Biotech Inc.

09/23/2020 | Press release | Distributed by Public on 09/23/2020 05:20

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate